协鑫集成：10月24日召开董事会会议

Group 1 - The core point of the article is that GCL-Poly Energy Holdings Limited (协鑫集成) announced the termination of a specific stock issuance plan during its board meeting held on October 24, 2025 [1] - For the first half of 2025, GCL-Poly's revenue composition is entirely from the solar energy industry, accounting for 100.0% [1] - As of the report date, GCL-Poly's market capitalization stands at 14.4 billion yuan [1] Group 2 - The article also highlights that the Chinese innovative drug sector has generated $80 billion in overseas licensing deals this year, indicating a robust performance in the biopharmaceutical secondary market [1] - A conversation with Lu Gang, a partner at Chuangdong Investment, reveals that while the secondary market is thriving, the primary market is facing challenges in fundraising [1]